Begin main content

Call for Patient Input: Akynzeo

November 16, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Akynzeo Brand name Generic name Manufacturer I...

CDR Update 130

November 13, 2017
See CDR Update 130 for important news and information regarding the CADTH Common Drug Review.

Call for Patient Input: brodalumab

November 8, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. brodalumab Brand name Generic name Manufacture...

CADTH Expert Panel Recommends Home-Based Dialysis In Patients With End-Stage Kidney Disease

November 8, 2017
Ottawa, ON (November 8, 2017) — For Canadians living with end-stage kidney disease, undergoing dialysis at home should be considered as an alternative to regular visits to a dialysis centre, according to new evidence and expert recommendations from CADTH. “The evidence tells us that in-centre and home-based dialysis offer similar benefits in ter...